Half of over-60s ignore lifesaving bowel cancer screening

September 5, 2018, Cancer Research UK

Half (51%) of people invited to bowel screening for the first time in 2015 didn't take part, according to the latest figures from Cancer Research UK published today (Wednesday) in the European Journal of Cancer.

Averaged figures from 2010-15 in England showed that those from deprived areas were less likely to participate (43%) than those in wealthier regions (57%) and more women (56%) than men (47%) returned samples from the screening kits sent out in the post.

People who lived in ethnically diverse neighbourhoods were also less likely to take part (41%) than those who didn't (56%).

The current screening kit requires small stool samples to be taken on three separate days and posted back to the screening unit in specially sealed envelopes.

Researchers from University College London (UCL) examined the anonymous data from 4.4 million men and women aged between 60 and 64 who were sent a home kit for the first time as part of the English Bowel Cancer Screening Programme between 2010 and 2015.

They found that 53% returned samples in 2010, but this dropped to 49% by 2015.

For those who choose to take part in screening the risk of dying from bowel is 25% lower than for those who don't.

Lead researcher Dr. Christian von Wagner from UCL said: "The fact fewer and fewer people are returning their kits and that inequalities in the system are widening, is very worrying. There is an urgent need to revolutionise bowel cancer screening because the earlier cancer is spotted, the more lives can be saved.

"Research has shown the introduction of a new test called the Faecal Immunochemical Test (FIT) would encourage more people to take part, with a 7% increase in uptake. The sooner this can be introduced, the more lives will be saved."

FIT is a new test due to be introduced into the national bowel screening programme in England this autumn. It is easier to use than the current test as it only requires one sample instead of three and is more accurate in detecting potential cancers.

Sara Hiom, director of early diagnosis at Cancer Research UK, said: "Our bowel cancer screening programme is extremely effective at detecting early disease before symptoms show themselves, so it's very concerning that so many people are missing out on this potential health benefit.

"We have good evidence to suggest that the new FIT screening test—which is easier to do—will help reduce barriers and result in more people choosing to take up their invitation. So the sooner it is introduced, and made available to everyone eligible, the better.

"When bowel cancer is diagnosed at an early stage, as through screening, more than 9 in 10 people survive but when it is detected in the late stages, survival falls to less than 1 in 10. Every year around 28,500 people aged 60 and over are diagnosed with bowel cancer in England.

Improved screening will undoubtedly reduce deaths from a cancer that affects so many lives."

Anne Parmenter, 63, from South London was diagnosed with bowel cancer through . Following surgery and chemotherapy she is now doing well and back at work as a classroom assistant.

She said: "On my 60th birthday, I received a testing kit in the post from the NHS. I wasn't going to do it but, in the end, I thought it was daft not to and sent it back. The following Tuesday I received a letter asking me to go to hospital for more tests.

"I had no symptoms before and didn't feel unwell, so I feel that kit saved my life. The cancer has changed how I look at life because none of us know what is around the corner. Three years ago, I had no idea of what was to come but I am now slowly recovering and getting back to normal."

Explore further: Emergency hospital visits more common among most deprived bowel cancer patients

More information: Hirst Y, Stoffel S, Baio G, McGregor L, von Wagner C, Uptake of the English Bowel (Colorectal) Cancer Screening Programme: an update 5 years after full roll-out, European Journal of Cancer (2018), DOI: 10.1016/j.ejca.2018.07.135

Related Stories

Emergency hospital visits more common among most deprived bowel cancer patients

August 15, 2018
Bowel cancer patients living in the most deprived areas have up to 13% higher proportions of emergency hospital admissions before a diagnosis than patients living in the least deprived areas, according to a study funded by ...

More than a third of people with abnormal results drop out of bowel cancer screening

January 6, 2015
Almost 40 per cent of people who have abnormal results from bowel cancer screening tests and are referred for further investigation ignore their next screening invitation two years later, according to a Cancer Research UK ...

Bowel screening kit with extras could help save more lives

October 7, 2015
Thousands more people would take part in bowel cancer screening if the kit included extras, such as gloves and "poo catchers", according to a Cancer Research UK study published today in Biomed Research International.

NHS bowel scope uptake boosted by a fifth when patients sent reassuring reminders

January 15, 2018
Bowel scope screening uptake increased by more than a fifth (21.5%) when people were sent additional reminders with a leaflet that addressed common concerns, according to a new study funded by Cancer Research UK.

Over fifty per cent do not go for new bowel cancer test

September 21, 2015
More than half of people invited to take a new bowel cancer screening test didn't take up the opportunity – even though it could stop them developing or dying from the disease, according to a Cancer Research UK report published ...

Major increase in bowel cancer screening uptake shown with new screening test

March 27, 2015
A large pilot study of a new bowel cancer screening test has demonstrated a major increase in participation rates across population groups.

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.